Skip to content

ARCHIMEDES: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ARCHIMEDES

BE 0457.013.322
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€38,387
2024 · €72,791-€34,404
Equity
€64,898
2024 · €86,511-€21,613
Cash
€66,225
2024 · €101,583-€35,358
Balance sheet total
€76,775
2024 · €114,855-€38,080

Largest movements

2024 to 2025
Assets
  • Cash -€35,358

    down €35,358 (-34.8%), from €101,583 to €66,225

    mainly Contributions, distributions and other (-€60,000) and Accrued charges and deferred income (-€16,408)

  • Stocks and contracts -€1,671

    down €1,671 (-26.8%), from €6,236 to €4,565

Equity and liabilities
  • Profit (loss) carried forward -€21,613

    down €21,613 (-32.7%), from €66,051 to €44,438

  • Accrued charges and deferred income -€16,408

    no longer reported in 2025 (was €16,408)

  • Other debts +€7,623

    new in 2025: €7,623

  • Tax, wage and social debts -€7,000

    no longer reported in 2025 (was €7,000)

Income statement
  • Gross operating margin -€34,623

    down €34,623 (-46.8%), from €73,933 to €39,310

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €72,791
Gross operating margin -€34,623
Depreciation +€142
Financial charges +€77
Result 2025 €38,387
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€24,642
Investment €0
Financing -€60,000
Cash 2024 €101,583
Net result for the year +€38,387
Depreciation +€911
Stocks and contracts +€1,671
Receivables within one year +€140
Trade debts -€682
Tax, wage and social debts -€7,000
Other debts +€7,623
Accrued charges and deferred income -€16,408
Contributions, distributions and other -€60,000
Cash 2025 €66,225
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €114,855 €76,775 -€38,080 -33.2%
Fixed assets 21/28 €911 - -€911
Tangible fixed assets 22/27 €911 - -€911
Plant, machinery and equipment 23 €704 - -€704
Furniture and vehicles 24 €207 - -€207
Current assets 29/58 €113,944 €76,775 -€37,169 -32.6%
Stocks and contracts in progress 3 €6,236 €4,565 -€1,671 -26.8%
Stocks 30/36 €6,236 €4,565 -€1,671 -26.8%
Amounts receivable within one year 40/41 €6,125 €5,985 -€140 -2.3%
Trade receivables 40 €6,125 €5,985 -€140 -2.3%
Cash at bank and in hand 54/58 €101,583 €66,225 -€35,358 -34.8%
Total equity and liabilities 10/49 €114,855 €76,775 -€38,080 -33.2%
Equity 10/15 €86,511 €64,898 -€21,613 -25.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Capital 10 €18,600 €18,600 = 0.0%
Issued capital 100 €18,600 €18,600 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Legal reserve 130 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €66,051 €44,438 -€21,613 -32.7%
Amounts payable 17/49 €28,344 €11,877 -€16,467 -58.1%
Amounts payable within one year 42/48 €11,936 €11,877 -€59 -0.5%
Trade debts 44 €4,936 €4,254 -€682 -13.8%
Suppliers 440/4 €4,936 €4,254 -€682 -13.8%
Taxes, remuneration and social security 45 €7,000 - -€7,000
Taxes 450/3 €7,000 - -€7,000
Other amounts payable 47/48 - €7,623 +€7,623
Accrued charges and deferred income 492/3 €16,408 - -€16,408
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,053 €911 -€142 -13.5%
Gross operating margin 9900 €73,933 €39,310 -€34,623 -46.8%
Operating profit (loss) 9901 €72,880 €38,399 -€34,481 -47.3%
Financial charges 65/66B €89 €12 -€77 -86.5%
Recurring financial charges 65 €89 €12 -€77 -86.5%
Profit (loss) for the period before taxes 9903 €72,791 €38,387 -€34,404 -47.3%
Profit (loss) for the period 9904 €72,791 €38,387 -€34,404 -47.3%
Profit (loss) for the period to be appropriated 9905 €72,791 €38,387 -€34,404 -47.3%

Source: filed annual accounts (NBB), financial years ended 30 April 2024 and 30 April 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.